Brief: Harpoon Therapeutics Q2 revenue USD 20.221 million
09/08/2023 21:42
Aug 9 (Reuters) - Harpoon Therapeutics Q2 net income USD 1.061 million. * Q2 operating expenses USD 17.728 million * Q2 revenue USD 20.221 million
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals